Graham Scholefield is a Manager with Catenion and lives in Berlin.
Since joining Catenion he has taken a keen interest in the reimbursement of pharmaceuticals by payers, an increasingly important topic in today’s world. A notable outcome of this is a two-part publication in European Biopharmaceutical Review which discusses a pragmatic methodology to integrate payer needs into R&D decision making. In addition to this, Graham also conducted an in-depth review of R&D productivity of the top 30 pharmaceutical companies, which is now published yearly in in vivo.
Prior to this, during his PhD and subsequent Postdoctoral position, Graham made a significant contribution to the field of DNA replication initiation with several high impact publications in world leading journals.
Throughout his professional and educational career he has worked on various projects using data and competitive analysis, due diligence, pharmaceutical R&D portfolio review and in-depth market research.
Graham is also a keen Thai boxer and road cyclist.
Graham studied for is PhD in Biochemistry and Molecular Biology under the supervisor of former Oxford Professor and Institute Director Jeff Errington FRS at Newcastle University in the UK, with his thesis subsequently being awarded the University Doctoral Prize Medal. Prior to this he completed an MRes in Medical and Molecular Biosciences and a BSc in Medical Microbiology and Immunology also at Newcastle University.
- Strategic decision making
- Pricing and reimbursement of pharmaceuticals
- Advanced data analysis and economic modelling
- R&D portfolio review and evaluation
- Market research and competitive analysis